Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$430M |
| 3 |
Verizon
VZ
|
+$390M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Broadcom
AVGO
|
+$212M |
Top Sells
| 1 |
iShares MBS ETF
MBB
|
+$560M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$537M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$144M |
| 4 |
Oracle
ORCL
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| 1 | Technology | 20.19% |
| 2 | Financials | 13.06% |
| 3 | Healthcare | 12.04% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Rhythm Pharmaceuticals
RYTM
$6.39B
| $5.24M | ﹤0.01% |
267,631
+15,409
| +6% | +$302K |
|
2327
Telos
TLS
$490M
| $5.24M | ﹤0.01% |
154,007
+42,931
| +39% | +$1.46M |
|
2328
Northfield Bancorp
NFBK
$492M
| $5.23M | ﹤0.01% |
318,614
-1,409
| -0.4% | -$23.1K |
|
2329
Generation Bio
GBIO
$39.9M
| $5.22M | ﹤0.01% |
19,389
+1,156
| +6% | +$311K |
|
|
AEVA
2330
Aeva Technologies
AEVA
$903M
| $5.21M | ﹤0.01% |
+98,648
| New | +$5.21M |
|
|
CCF
2331
DELISTED
Chase Corporation
CCF
| $5.21M | ﹤0.01% |
50,747
+870
| +2% | +$89.3K |
|
2332
RE/MAX Holdings
RMAX
$195M
| $5.2M | ﹤0.01% |
155,940
+29,125
| +23% | +$971K |
|
2333
Personalis
PSNL
$519M
| $5.2M | ﹤0.01% |
205,373
+20,624
| +11% | +$522K |
|
|
NWLI
2334
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $5.19M | ﹤0.01% |
23,131
+196
| +0.9% | +$44K |
|
2335
Theravance Biopharma
TBPH
$720M
| $5.18M | ﹤0.01% |
356,544
+23,060
| +7% | +$335K |
|
2336
BrightView Holdings
BV
$1.32B
| $5.17M | ﹤0.01% |
320,887
+49,600
| +18% | +$800K |
|
|
BTRS
2337
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $5.15M | ﹤0.01% |
408,380
+127,844
| +46% | +$1.61M |
|
|
WSR
2338
Whitestone REIT
WSR
$664M
| $5.15M | ﹤0.01% |
624,337
+136,213
| +28% | +$1.12M |
|
|
SUMO
2339
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $5.15M | ﹤0.01% |
249,416
+146,812
| +143% | +$3.03M |
|
|
ATCO
2340
DELISTED
Atlas Corp.
ATCO
| $5.15M | ﹤0.01% |
361,126
-34,693
| -9% | -$494K |
|
|
VBIV
2341
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $5.15M | ﹤0.01% |
51,187
+1,529
| +3% | +$154K |
|
2342
Bionano Genomics
BNGO
$18.2M
| $5.14M | ﹤0.01% |
1,168
+1,057
| +952% | +$4.65M |
|
2343
Surmodics
SRDX
$457M
| $5.14M | ﹤0.01% |
94,645
+1,664
| +2% | +$90.3K |
|
2344
Titan Machinery
TITN
$451M
| $5.11M | ﹤0.01% |
165,179
+14,331
| +10% | +$443K |
|
2345
Amphastar Pharmaceuticals
AMPH
$1.3B
| $5.11M | ﹤0.01% |
253,387
+5,488
| +2% | +$111K |
|
|
TVRD
2346
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $5.08M | ﹤0.01% |
9,895
+335
| +4% | +$172K |
|
|
CHUY
2347
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $5.08M | ﹤0.01% |
136,359
+2,176
| +2% | +$81.1K |
|
2348
ALX Oncology
ALXO
$56.8M
| $5.07M | ﹤0.01% |
92,704
+1,734
| +2% | +$94.8K |
|
|
AERI
2349
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.05M | ﹤0.01% |
315,652
+16,851
| +6% | +$270K |
|
2350
Autohome
ATHM
$3.48B
| $5.05M | ﹤0.01% |
78,965
-2,055
| -3% | -$131K |
|